Product Details
Erythro-Base
Erythromycin Base250 mg
Tablet
DIN/PIN/NPN
00682020
Manufacturer
A A Pharma Inc.
Formulary Listing Date
1996-10-01
Unit Price
0.1865
Amount MOH Pays
0.1865
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Antibiotics, Erythromycins (8:12:12): Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.
ATC Code
J01FA01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 00244635 | Erythromid | NA | NA |
| 00682020 | Erythro-Base | 0.1865 | 0.1865 |